Product NDC: | 55154-3915 |
Proprietary Name: | SOLU-MEDROL |
Non Proprietary Name: | methylprednisolone sodium succinate |
Active Ingredient(s): | 125 mg/mL & nbsp; methylprednisolone sodium succinate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-3915 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011856 |
Marketing Category: | NDA |
Start Marketing Date: | 19590402 |
Package NDC: | 55154-3915-5 |
Package Description: | 5 VIAL, PATENT DELIVERY SYSTEM in 1 BAG (55154-3915-5) > 2 mL in 1 VIAL, PATENT DELIVERY SYSTEM |
NDC Code | 55154-3915-5 |
Proprietary Name | SOLU-MEDROL |
Package Description | 5 VIAL, PATENT DELIVERY SYSTEM in 1 BAG (55154-3915-5) > 2 mL in 1 VIAL, PATENT DELIVERY SYSTEM |
Product NDC | 55154-3915 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methylprednisolone sodium succinate |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19590402 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
Strength Number | 125 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |